DrugPatentWatch Database Preview
Dow Pharm Company Profile
What is the competitive landscape for DOW PHARM, and when can generic versions of DOW PHARM drugs launch?
DOW PHARM has fourteen approved drugs.
There are fourteen US patents protecting DOW PHARM drugs.
There are fifty-nine patent family members on DOW PHARM drugs in twenty-two countries and twenty-four supplementary protection certificates in twelve countries.
Summary for Dow Pharm
| International Patents: | 59 |
| US Patents: | 14 |
| Tradenames: | 12 |
| Ingredients: | 10 |
| NDAs: | 14 |
| Patent Litigation for Dow Pharm: | See patent lawsuits for Dow Pharm |
Drugs and US Patents for Dow Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dow Pharm | JUBLIA | efinaconazole | SOLUTION;TOPICAL | 203567-001 | Jun 6, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Dow Pharm | JUBLIA | efinaconazole | SOLUTION;TOPICAL | 203567-001 | Jun 6, 2014 | RX | Yes | Yes | 9,662,394 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Dow Pharm | NUTRACORT | hydrocortisone | LOTION;TOPICAL | 087644-001 | Aug 24, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Dow Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Dow Pharm | OXSORALEN-ULTRA | methoxsalen | CAPSULE;ORAL | 019600-001 | Oct 30, 1986 | 4,454,152 | ➤ Sign Up |
| Dow Pharm | ONEXTON | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 050819-002 | Nov 24, 2014 | 5,733,886 | ➤ Sign Up |
| Dow Pharm | ACANYA | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 050819-001 | Oct 23, 2008 | 6,117,843 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for DOW PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Gel | 1.2%/2.5% | ➤ Subscribe | 2012-12-20 |
| ➤ Subscribe | Topical Solution | 10% | ➤ Subscribe | 2018-06-06 |
| ➤ Subscribe | Gel | 1.2%/3.75% | ➤ Subscribe | 2015-09-30 |
Non-Orange Book US Patents for Dow Pharm
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 9,693,988 | Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Dow Pharm Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1146894 | ➤ Sign Up |
| South Korea | 20100108555 | ➤ Sign Up |
| Japan | 5872656 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Dow Pharm Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2008000041 | Germany | ➤ Sign Up | PRODUCT NAME: ADAPALEN IN KOMBINATION MIT BENZOYLPEROXID; NAT. REGISTRATION NO/DATE: 67913.00.00 20080229; FIRST REGISTRATION: DAENEMARK 40440 20071218 |
| C0042 | Belgium | ➤ Sign Up | PRODUCT NAME: 2-(2-BENZOYL-SUBSTITUE)-1,3-CYCLOHEXANE-DIONES; REGISTRATION NO/DATE: 8452/B 19930121 |
| 2013025,C1304992 | Lithuania | ➤ Sign Up | PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.
